---
title: "Takeda Pharmaceutical Insiders Sold Shares Worth Over $3.5M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295731657.md"
description: "Takeda Pharmaceutical insiders sold shares worth over $3.5M on August 10, 2026. CEO Kim Julie So-Young sold $1.52M, while Global General Counsel Furney and IBU President Platford sold approximately $528K and $532K respectively. These were mandatory sales to cover taxes on equity vesting. CHRO Greenway also sold shares for ~$606K."
datetime: "2026-08-13T01:50:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295731657.md)
  - [en](https://longbridge.com/en/news/295731657.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295731657.md)
generator: "portal-rs"
---

# Takeda Pharmaceutical Insiders Sold Shares Worth Over $3.5M

Nicola Deidre Petal Greenway, an officer serving as Chief Human Resources Officer, reported two direct sales of American Depositary Shares on 2026-08-10 for 975 shares at $17.50 and 33,628 shares at $17.5067, for total proceeds of $605,777 and a weighted average price of approximately $17.506; following the reported transactions, Greenway directly owns 59,803 American Depositary Shares.

Natalie Anne Marie Furney, an officer serving as Global General Counsel, executed a mandatory sale to cover taxes associated with the vesting of equity awards, disposing of 30,868 American Depositary Shares on 2026-08-10 at a weighted average selling price of $17.10 per share for total proceeds of $527,842; following the transaction, Furney directly beneficially owns 204,298 American Depositary Shares.

Platford Giles Richard, an officer serving as President, IBU, executed a mandatory sale to cover taxes associated with the vesting of equity awards, disposing of 31,083 American Depositary Shares on 2026-08-10 at a weighted average price of $17.10 per share for total proceeds of $531,519; after the transaction, Platford Giles Richard directly owned 315,838 American Depositary Shares.

Kim Julie So-Young, a direct shareholder serving as President and CEO, reported a mandatory sale to cover taxes associated with the vesting of equity awards, disposing of American Depositary Shares on 2026-08-10 at a weighted average price of $17.10 per share for total proceeds of $1,523,439; after the transaction, the reporting person directly owns 391,489 American Depositary Shares.

| Reporter Name             | Relationship           | Type | Amount     | SEC Filing |
| ------------------------- | ---------------------- | ---- | ---------- | ---------- |
| Furney Natalie Anne Marie | Global General Counsel | Sell | $527,842   | Form 4     |
| Platford Giles Richard    | President, IBU         | Sell | $531,519   | Form 4     |
| Kim Julie So-Young        | President and CEO      | Sell | $1,523,439 | Form 4     |

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [TAK.US](https://longbridge.com/en/quote/TAK.US.md)
- [4502.JP](https://longbridge.com/en/quote/4502.JP.md)

## Related News & Research

- [Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO](https://longbridge.com/en/news/297377145.md)
- [Takeda’s Orzeyful secured Japan MHLW approval for narcolepsy type 1](https://longbridge.com/en/news/296890461.md)
- [Takeda Secures FDA Approval For First-In-Class Blood Cancer Drug](https://longbridge.com/en/news/297545595.md)
- [Weekly Recap: MIMRYLO license terms and Orzeyful FDA approval](https://longbridge.com/en/news/297567010.md)
- [ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1 | TAK Stock News](https://longbridge.com/en/news/296745786.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**